|
시장보고서
상품코드
2089733
폴리카프로락톤 필러 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)Polycaprolactone Filler Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
폴리카프로락톤 필러 시장 개요
세계의 폴리카프로락톤 필러 시장 규모는 2025년에 5,730만 달러로 평가되며, 2026년 6,250만 달러에서 2033년까지 1억 1,550만 달러로 성장하며, 2026-2033년 CAGR은 9.2%에 달할 것으로 예측됩니다.
아시아태평양은 2025년에 36.3%라는 가장 높은 매출 점유율을 기록하며 세계 시장을 주도했습니다. 이 시장은 효과가 오래 지속되고 침습성이 낮은 미용 시술에 대한 수요가 증가함에 따라 꾸준히 성장하고 있습니다.
폴리카프로락톤(PCL)은 생체자극성 필러로 널리 사용되고 있습니다. 이는 즉시 볼륨을 회복시켜 줄 뿐만 아니라, 시간이 지남에 따라 자연스러운 콜라겐 생성을 촉진합니다. 이러한 이중 작용 메커니즘 덕분에, 특히 히알루론산 필러를 대체할 수 있는 더 오래 지속되는 치료법을 찾는 환자들 사이에서 얼굴 회춘 치료에 이 방법이 빠르게 확산되고 있습니다.
임상적 근거 또한 그 지속성과 유효성을 지원하고 있으며, 연구 결과에 따르면 시술 후 최대 24개월 동안 주름의 심각도와 미용적 결과에서 지속적인 개선이 나타나는 것으로 나타났습니다. '비순주름 교정에 있어서 폴리카프로락톤의 응용'이라는 제목의 임상 연구에서는 얼굴의 주름과 주름살 교정을 목적으로 한 폴리카프로락톤(PCL) 기반 진피 필러(Ellanse-S 및 Ellanse-M)의 장기적인 안전성과 유효성이 평가되었습니다.
PCL 필러 업계의 주요 성장 요인 중 하나는 비수술적 안면 볼륨 회복 시술에 대한 수요가 증가하고 있다는 점입니다. 특히 선진국이나 신흥 국가에서 고령화가 진행되는 가운데, 위험이 적고 회복 기간이 짧다는 점 때문에 외과적 안면 리프팅 대신 주사 요법을 적극적으로 선택하는 경향이 있습니다. PCL 기반 필러는 즉각적인 개선 효과뿐만 아니라, 콜라겐 생성을 촉진하여 장기적으로 피부 두께를 증가시키기 때문에 얼굴 볼륨 회복이나 주름·주름살 교정 등의 용도로 주목받고 있습니다. 또 다른 중요한 촉진요인은 액상 PCL 제제 및 하이브리드 필러 분야의 기술 혁신이 진전되고 있다는 점입니다. 이로 인해 주입이 더 쉬워졌으며, 치료의 적용 범위가 확대되고 있습니다. 액상 PCL 제품은 눈 주위의 회춘이나 피부 질 개선 등, 제어된 균일한 분포가 필수적인 민감한 부위에서의 사용이 점점 더 늘어나고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 개요
제3장 폴리카프로락톤 필러 시장 : 변수, 동향, 범위
제4장 폴리카프로락톤 필러 시장 : 제품별 추정·동향 분석
제5장 폴리카프로락톤 필러 시장 : 용도별 추정·동향 분석
제6장 폴리카프로락톤 필러 시장 : 최종 사용별 추정·동향 분석
제7장 폴리카프로락톤 필러 시장 : 지역별 추정·동향 분석
제8장 경쟁 구도
KSA 26.07.20Polycaprolactone Filler Market Summary
The global polycaprolactone filler market size was valued at USD 57.3 million in 2025 and is projected to grow from USD 62.5 million in 2026 to USD 115.5 million by 2033, at a CAGR of 9.2% from 2026 to 2033. Asia Pacific dominated the global market with the largest revenue share of 36.3% in 2025. The market is witnessing steady expansion due to the rising demand for long-lasting, minimally invasive aesthetic procedures.
Polycaprolactone (PCL) is widely used as a biostimulatory filler, meaning it not only restores immediate volume but also stimulates natural collagen production over time. This dual mechanism is driving strong adoption in facial rejuvenation treatments, especially among patients seeking longer-lasting alternatives to hyaluronic acid fillers.
Clinical evidence also supports its durability and efficacy, with studies showing sustained improvement in wrinkle severity and aesthetic outcomes for up to 24 months post-treatment. The clinical study titled "Polycaprolactone for the Correction of Nasolabial Folds", evaluated the long-term safety and efficacy of polycaprolactone (PCL)-based dermal fillers (Ellanse-S and Ellanse-M) for facial wrinkle and fold correction.
One of the major growth drivers of the PCL filler industry is the increasing preference for non-surgical facial volume restoration procedures. Aging populations, particularly in developed and emerging economies, are actively opting for injectable solutions instead of surgical facelifts due to lower risk and shorter recovery time. PCL-based fillers are gaining traction in applications such as facial volume restoration and wrinkle & fold correction, as they provide both immediate correction and long-term skin thickening through collagen stimulation. Another key driver is the rising innovation in liquid PCL formulations and hybrid fillers, which are improving injection ease and expanding treatment versatility. Liquid PCL products are increasingly used in delicate areas, such as periorbital rejuvenation and skin quality improvement, where controlled, even distribution is critical.
Global Polycaprolactone Filler Market Report Segmentation
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global polycaprolactone filler market report based on product, application, end use, and region:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Microsphere Fillers
- Liquid PCL Formulations
- Hybrid Fillers
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Facial Volume Restoration
- Wrinkle & Fold Correction
- Skin Quality Improvement & Biostimulation
- Periorbital Rejuvenation
- Non-Surgical Rhinoplasty
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Aesthetic Clinics & Medical Spas
- Dermatology Clinics
- Hospital
- Others
- Country Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Norway
- Denmark
- Sweden
- Asia Pacific
- China
- Japan
- South Korea
- Thailand
- Australia
- India
- Latin America
- Brazil
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Edn Use outlook
- 2.2.4. Region outlook
- 2.3. Competitive Insights
Chapter 3. PCL Filler Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. PCL Filler Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
- 3.3.1. Industry Analysis - Porter's
Chapter 4. PCL Filler Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. PCL Filler Market: Product Movement Analysis
- 4.3. PCL Filler Market by Product Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 4.5. Microsphere Fillers
- 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.6. Liquid PCL Formulations
- 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.7. Hybrid Fillers
- 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. PCL Filler Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. PCL Filler Market: Needle Length Movement Analysis
- 5.3. PCL Filler Market by Needle Length Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 5.5. Facial Volume Restoration
- 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Wrinkle & Fold Correction
- 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Skin Quality Improvement & Biostimulation
- 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.8. Periorbital Rejuvenation
- 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.9. Non-Surgical Rhinoplasty
- 5.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. PCL Filler Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. PCL Filler Market: Therapy Movement Analysis
- 6.3. PCL Filler Market by Therapy Outlook (USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 6.5. Aesthetic Clinics & Medical Spas
- 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.6. Dermatology Clinics
- 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.7. Hospital
- 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.8. Others
- 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. PCL Filler Market: Regional Estimates & Trend Analysis
- 7.1. Regional Dashboard
- 7.2. Regional PCL Filler Market Movement Analysis
- 7.3. PCL Filler Market: Regional Estimates & Trend Analysis by Product & Needle Length
- 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
- 7.5. North America
- 7.5.1. North America PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Reimbursement Scenario
- 7.5.2.5. U.S. PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Reimbursement Scenario
- 7.5.3.5. Canada PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.4. Mexico
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Competitive Scenario
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. Reimbursement Scenario
- 7.5.4.5. Mexico PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Europe
- 7.6.1. Europe PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. UK
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Reimbursement Scenario
- 7.6.2.5. UK PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.3. Germany
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Reimbursement Scenario
- 7.6.3.5. Germany PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.4. France
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. Reimbursement Scenario
- 7.6.4.5. France PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.5. Italy
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Reimbursement Scenario
- 7.6.5.5. Italy PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.6. Spain
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Competitive Scenario
- 7.6.6.3. Regulatory Framework
- 7.6.6.4. Reimbursement Scenario
- 7.6.6.5. Spain PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.7. Denmark
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Competitive Scenario
- 7.6.7.3. Regulatory Framework
- 7.6.7.4. Reimbursement Scenario
- 7.6.7.5. Denmark PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.8. Sweden
- 7.6.8.1. Key Country Dynamics
- 7.6.8.2. Competitive Scenario
- 7.6.8.3. Regulatory Framework
- 7.6.8.4. Reimbursement Scenario
- 7.6.8.5. Sweden PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.9. Norway
- 7.6.9.1. Key Country Dynamics
- 7.6.9.2. Competitive Scenario
- 7.6.9.3. Regulatory Framework
- 7.6.9.4. Reimbursement Scenario
- 7.6.9.5. Norway PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Asia Pacific PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.2. Japan
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. Reimbursement Scenario
- 7.7.2.5. Japan PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.3. China
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Reimbursement Scenario
- 7.7.3.5. China PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.4. India
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. Reimbursement Scenario
- 7.7.4.5. India PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Reimbursement Scenario
- 7.7.5.5. South Korea PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.6. Australia
- 7.7.6.1. Key Country Dynamics
- 7.7.6.2. Competitive Scenario
- 7.7.6.3. Regulatory Framework
- 7.7.6.4. Reimbursement Scenario
- 7.7.6.5. Australia PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.7. Thailand
- 7.7.7.1. Key Country Dynamics
- 7.7.7.2. Competitive Scenario
- 7.7.7.3. Regulatory Framework
- 7.7.7.4. Reimbursement Scenario
- 7.7.7.5. Thailand PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8. Latin America
- 7.8.1. Latin America PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.2. Brazil
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory Framework
- 7.8.2.4. Reimbursement Scenario
- 7.8.2.5. Brazil PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.3. Argentina
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory Framework
- 7.8.3.4. Reimbursement Scenario
- 7.8.3.5. Argentina PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.9. Middle East & Africa
- 7.9.1. Middle East & Africa PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.9.2. South Africa
- 7.9.2.1. Key Country Dynamics
- 7.9.2.2. Competitive Scenario
- 7.9.2.3. Regulatory Framework
- 7.9.2.4. Reimbursement Scenario
- 7.9.2.5. South Africa PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.9.3. Saudi Arabia
- 7.9.3.1. Key Country Dynamics
- 7.9.3.2. Competitive Scenario
- 7.9.3.3. Regulatory Framework
- 7.9.3.4. Reimbursement Scenario
- 7.9.3.5. Saudi Arabia PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.9.4. UAE
- 7.9.4.1. Key Country Dynamics
- 7.9.4.2. Competitive Scenario
- 7.9.4.3. Regulatory Framework
- 7.9.4.4. Reimbursement Scenario
- 7.9.4.5. UAE PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.9.5. Kuwait
- 7.9.5.1. Key Country Dynamics
- 7.9.5.2. Competitive Scenario
- 7.9.5.3. Regulatory Framework
- 7.9.5.4. Reimbursement Scenario
- 7.9.5.5. Kuwait PCL Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Market Participant Categorization
- 8.2. Key Company Profiles
- 8.2.1. Sinclair Pharma
- 8.2.1.1. Company Overview
- 8.2.1.2. Financial Performance
- 8.2.1.3. Product Benchmarking
- 8.2.1.4. Strategic Initiatives
- 8.2.2. Samyang Holdings
- 8.2.2.1. Company Overview
- 8.2.2.2. Financial Performance
- 8.2.2.3. Product Benchmarking
- 8.2.2.4. Strategic Initiatives
- 8.2.3. DEXLEVO Inc.
- 8.2.3.1. Company Overview
- 8.2.3.2. Financial Performance
- 8.2.3.3. Product Benchmarking
- 8.2.3.4. Strategic Initiatives
- 8.2.4. Jinan Grandwill Medical Technology Co., Ltd
- 8.2.4.1. Company Overview
- 8.2.4.2. Financial Performance
- 8.2.4.3. Product Benchmarking
- 8.2.4.4. Strategic Initiatives
- 8.2.5. HIXMED CO., LTD
- 8.2.5.1. Company Overview
- 8.2.5.2. Financial Performance
- 8.2.5.3. Product Benchmarking
- 8.2.5.4. Strategic Initiatives
- 8.2.6. DERMAKOR
- 8.2.6.1. Company Overview
- 8.2.6.2. Financial Performance
- 8.2.6.3. Product Benchmarking
- 8.2.6.4. Strategic Initiatives
- 8.2.7. ZK MediGroup
- 8.2.7.1. Company Overview
- 8.2.7.2. Financial Performance
- 8.2.7.3. Product Benchmarking
- 8.2.7.4. Strategic Initiatives
- 8.2.8. ACMEDI KOREA Co.
- 8.2.8.1. Company Overview
- 8.2.8.2. Financial Performance
- 8.2.8.3. Product Benchmarking
- 8.2.8.4. Strategic Initiatives
- 8.2.1. Sinclair Pharma
